Head-to-head studies show people on tirzepatide lost an average 20.2% of their body weight compared to 13.7% with semaglutide over 72 weeks
Key Differences from Other Solvents When compared to other solvents, bacteriostatic water stands out for its preservative properties that inhibit the growth of bacteria
It is not yet FDA approved, but Phase 3 data from the TRIUMPH-4 trial (December 2025) showed an average of 28.7% body weight loss at 68 weeks at the 12 mg dose the highest ever recorded in a pharmacological weight loss trial
Google Scholar Brandt, K., Leifert, C., Sanderson, R., and Seal, C
Advanced copper peptide formula for skin, hair, and tissue support
Patients on immunosuppressants or blood thinners are also assessed carefully